SCHEMBL26401192

SCHEMBL26401192

COCc1ccc(C(C)=O)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.43
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
PKM P14618 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
THPO P40225 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
KMT2A Q03164 1/20 0.42
HIF1A Q16665 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2631698 0.86 P4HTM (0.61) P4HTMALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL2631699 0.84 MAPK1 (0.59) P4HTMALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL24956361 0.81 PARP1 (0.48) P4HTMALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL26026729 0.81 ALDH1A1 (0.35) P4HTMALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL22912573 0.80 POLB (0.51) ALDH1A1KDM4EL3MBTL1LMNAMEN1
SCHEMBL622903 0.79 L3MBTL1 (0.50) P4HTMALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL14651299 0.79 P4HTM (0.47) P4HTMALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL31003087 0.79 POLB (0.40) P4HTMALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL17682180 0.78 P4HTM (0.46) P4HTMALDH1A1KDM4EL3MBTL1LMNA
SCHEMBL7995510 0.78 P4HTM (0.46) P4HTMALDH1A1KDM4EL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658656-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES Beone Medicines I GmbH (CH) 2025-12-10 EP disclosed
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEONE MEDICINES I GMBH (CH) 2025-11-13 US disclosed
WO-2024160276-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEIGENE, LTD. (KY) 2024-08-08 WO disclosed
US-11779018-B2 Heterocyclic compound and arthropod pest control composition containing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11779018-B2 Heterocyclic compound and arthropod pest control composition containing same C5, PRXL2A, NOX3 P4HTM 1873/4885ALDH1A1 2765/4885KDM4E 869/4885
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES DGKG, DGKA, DGKK P4HTM 4730/4885ALDH1A1 4075/4885KDM4E 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.